Accuracy of Echocardiography and Chest Tomography for Pulmonary Hypertension Screening in Patients Awaiting Lung Transplantation

Overview

Journal Einstein (Sao Paulo)

Specialty General Medicine

Date 2021 Dec 21

PMID 34932775

Citations 1

Authors

Luiza Helena Degani-Costa

Joao Paulo de Assis

Pedro Paulo Pisaniello Goncalves

Fernanda Gushken

Gilberto Szarf

Jose Eduardo Afonso Junior

Affiliations

Soon will be listed here.

Abstract

Objective: To examine the accuracy of a pulmonary hypertension screening strategy based on a combination of echocardiographic data and tomographic measurements (pulmonary artery diameter and pulmonary artery diameter to ascending aorta diameter ratio) in patients with chronic lung disease referred for lung transplantation.

Methods: A retrospective observational study with patients with pulmonary emphysema or fibrosis referred for transplantation between 2012 and 2016. Pulmonary hypertension was defined as mean pulmonary artery pressure ≥25mmHg, or between 21 and 24mmHg, with pulmonary vascular resistance >3 Wood units on right heart catheterization. Tomographic measurements were made by two independent radiologists.

Results: This sample comprised 13 patients with emphysema and 19 patients with pulmonary fibrosis. Of these, 18 had pulmonary hypertension. The level of agreement in tomographic measurements made by radiologists was high (intraclass correlation coefficients 0.936 and 0.940, for pulmonary artery diameter and pulmonary artery diameter to ascending aorta diameter ratio, respectively). Areas under the ROC curves constructed for pulmonary artery diameter, pulmonary artery diameter to ascending aorta diameter ratio, and pulmonary artery systolic pressure as predictors of pulmonary hypertension were 0.540, 0.629 and 0.783, respectively. The sensitivity, specificity and negative predictive value of pulmonary artery systolic pressure ≥40mmHg were 67%, 79% and 65%, respectively. The combined criterion (pulmonary artery diameter to ascending aorta diameter ratio >1 and/or pulmonary artery systolic pressure ≥40mmHg) achieved sensitivity of 72%, specificity of 79%, and a negative predictive value of 69%.

Conclusion: Measurements of pulmonary artery and ascending aorta diameter were highly reproducible. The association of pulmonary artery and aortic diameter >1 and/or pulmonary artery systolic pressure ≥40mmHg improved the sensitivity and the negative predictive value for pulmonary hypertension screening. This strategy demands prospective validation to assess safety and cost-effectiveness.

Citing Articles

Efficacy of computed tomography in diagnosing pulmonary hypertension: A systematic review and meta-analysis.

Chen R, Liao H, Deng Z, He Z, Zheng Z, Lu J Front Cardiovasc Med. 2022; 9:966257.

PMID: 36277788 PMC: 9579375. DOI: 10.3389/fcvm.2022.966257.

References

Nathan S, Barbera J, Gaine S, Harari S, Martinez F, Olschewski H . Pulmonary hypertension in chronic lung disease and hypoxia. Eur Respir J. 2018; 53(1). PMC: 6351338. DOI: 10.1183/13993003.01914-2018. View

Greiner S, Jud A, Aurich M, Hess A, Hilbel T, Hardt S . Reliability of noninvasive assessment of systolic pulmonary artery pressure by Doppler echocardiography compared to right heart catheterization: analysis in a large patient population. J Am Heart Assoc. 2014; 3(4). PMC: 4310406. DOI: 10.1161/JAHA.114.001103. View

Hayes Jr D, Black S, Tobias J, Kirkby S, Mansour H, Whitson B . Influence of Pulmonary Hypertension on Patients With Idiopathic Pulmonary Fibrosis Awaiting Lung Transplantation. Ann Thorac Surg. 2015; 101(1):246-52. DOI: 10.1016/j.athoracsur.2015.06.024. View

Wells J, Washko G, Han M, Abbas N, Nath H, Mamary A . Pulmonary arterial enlargement and acute exacerbations of COPD. N Engl J Med. 2012; 367(10):913-21. PMC: 3690810. DOI: 10.1056/NEJMoa1203830. View

Singh V, George M, Gries C . Pulmonary hypertension is associated with increased post-lung transplant mortality risk in patients with chronic obstructive pulmonary disease. J Heart Lung Transplant. 2015; 34(3):424-9. DOI: 10.1016/j.healun.2015.01.002. View

Weill D, Benden C, Corris P, Dark J, Davis R, Keshavjee S . A consensus document for the selection of lung transplant candidates: 2014--an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2014; 34(1):1-15. DOI: 10.1016/j.healun.2014.06.014. View

Truong Q, Massaro J, Rogers I, Mahabadi A, Kriegel M, Fox C . Reference values for normal pulmonary artery dimensions by noncontrast cardiac computed tomography: the Framingham Heart Study. Circ Cardiovasc Imaging. 2011; 5(1):147-54. PMC: 3275437. DOI: 10.1161/CIRCIMAGING.111.968610. View

Corte T, Keir G, Dimopoulos K, Howard L, Corris P, Parfitt L . Bosentan in pulmonary hypertension associated with fibrotic idiopathic interstitial pneumonia. Am J Respir Crit Care Med. 2014; 190(2):208-17. PMC: 4226056. DOI: 10.1164/rccm.201403-0446OC. View

Egan T, Murray S, Bustami R, Shearon T, McCullough K, Edwards L . Development of the new lung allocation system in the United States. Am J Transplant. 2006; 6(5 Pt 2):1212-27. DOI: 10.1111/j.1600-6143.2006.01276.x. View

10.

Chan A, Juarez M, Shelton D, MacDonald T, Li C, Lin T . Novel computed tomographic chest metrics to detect pulmonary hypertension. BMC Med Imaging. 2011; 11:7. PMC: 3073886. DOI: 10.1186/1471-2342-11-7. View

11.

Arcasoy S, Christie J, Ferrari V, St John Sutton M, Zisman D, Blumenthal N . Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am J Respir Crit Care Med. 2002; 167(5):735-40. DOI: 10.1164/rccm.200210-1130OC. View

12.

Rao R, Singh S, Sharma B, Agarwal V, Singh V . Sildenafil improves six-minute walk distance in chronic obstructive pulmonary disease: a randomised, double-blind, placebo-controlled trial. Indian J Chest Dis Allied Sci. 2011; 53(2):81-5. View

13.

Keller C, Gonwa T, White L, Rucci M, Visscher S, Kennedy C . Utilization and Cost Analysis of Lung Transplantation and Survival After 10 Years of Adapting the Lung Allocation Score. Transplantation. 2018; 103(3):638-646. PMC: 6200665. DOI: 10.1097/TP.0000000000002227. View

14.

Alkukhun L, Wang X, Ahmed M, Baumgartner M, Budev M, Dweik R . Non-invasive screening for pulmonary hypertension in idiopathic pulmonary fibrosis. Respir Med. 2016; 117:65-72. PMC: 4976395. DOI: 10.1016/j.rmed.2016.06.001. View

15.

Andersen K, Schultz H, Nyholm B, Iversen M, Gustafsson F, Carlsen J . Pulmonary hypertension as a risk factor of mortality after lung transplantation. Clin Transplant. 2016; 30(4):357-64. DOI: 10.1111/ctr.12692. View

16.

Villavicencio M, Axtell A, Osho A, Astor T, Roy N, Melnitchouk S . Single- Versus Double-Lung Transplantation in Pulmonary Fibrosis: Impact of Age and Pulmonary Hypertension. Ann Thorac Surg. 2018; 106(3):856-863. DOI: 10.1016/j.athoracsur.2018.04.060. View

17.

Kim C, Park J, Leem A, Song J, Kim S, Chung K . Prognostic value of pre-transplant mean pulmonary arterial pressure in lung transplant recipients: a single-institution experience. J Thorac Dis. 2018; 10(3):1578-1587. PMC: 5906309. DOI: 10.21037/jtd.2018.03.46. View

18.

Lin F, Devereux R, Roman M, Meng J, Jow V, Jacobs A . Cardiac chamber volumes, function, and mass as determined by 64-multidetector row computed tomography: mean values among healthy adults free of hypertension and obesity. JACC Cardiovasc Imaging. 2009; 1(6):782-6. DOI: 10.1016/j.jcmg.2008.04.015. View

19.

Shin S, King C, Puri N, Shlobin O, Brown A, Ahmad S . Pulmonary artery size as a predictor of outcomes in idiopathic pulmonary fibrosis. Eur Respir J. 2016; 47(5):1445-51. DOI: 10.1183/13993003.01532-2015. View

20.

Hayes Jr D, Tumin D, Budev M, Tobias J, St John R, Kukreja J . Adverse outcomes associated with pulmonary hypertension in chronic obstructive pulmonary disease after bilateral lung transplantation. Respir Med. 2017; 128:102-108. DOI: 10.1016/j.rmed.2017.04.010. View